Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review von Fishbane, Steven N., Nigwekar, Sagar

Volltext

Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients von Fishbane, Steven N, Singh, Ajay K, Cournoyer, Serge H, Jindal, Kailash K, Fanti, Paolo, Guss, Carrie D, Lin, Vivian H, Pratt, Raymond D, Gupta, Ajay

Volltext

Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin Studies von Fishbane, Steven N, Block, Geoff A, Evenepoel, Pieter, Budden, Jeffrey, Morin, Isabelle, Menzaghi, Frédérique, Wen, Warren, Lerma, Edgar V

Volltext

How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: Adjuvant therapies to reduce erythropoiesis-stimulating agent dose requirements von Shah, Hitesh H, Fishbane, Steven N

Volltext

Abstract P5-12-01: A novel gene expression signature prognostic for both locoregional and distant failure and predictive for adjuvant radiotherapy von Sjöström, M, Chang, SL, Fishbane, N, Davicioni, E, Zhao, SG, Hartman, L, Holmberg, E, Feng, FY, Speers, CW, Pierce, LJ, Malmström, P, Fernö, M, Karlsson, P

Volltext

S133Investigating genome wide dna methylation in airway and parenchymal fibroblasts from healthy individuals and individuals with copd von Clifford, R L, Fishbane, N, Rajasekar, P, Fisher, A J, Kobor, MS, Knox, A J, Hackett, T L

Volltext

Androgen Receptor Activity and Radiotherapeutic Sensitivity in African-American Men with Prostate Cancer: A Large Scale Gene Expression Analysis and Meta-Analysis of RTOG Trials von Spratt, D.E., Dess, R.T., Hartman, H.E., Mahal, B.A., Jackson, W.C., Soni, P.D., Alshalalfa, M., Fishbane, N., Zumsteg, Z.S., Shipley, W.U., Pisansky, T.M., Roach, M., Zhao, S.G., Speers, C., Davicioni, E., Schipper, M., Nguyen, P.L., Schaeffer, E.M., Feng, F.Y., Sandler, H.M.

Volltext

Development and Validation of Genomic Tools to Predict Extraprostatic Extension of Prostate Cancer, Opportunities for Personalizing Treatment von Hall, W.A., Liu, S., Fishbane, N., Xu, M.J., Davicioni, E., Mahal, B.A., Den, R.B., Dess, R.T., Jackson, W.C., Wong, A.C., Schaeffer, E.M., Karnes, R.J., Carroll, P., Nguyen, P.L., Lawton, C.A.F., Spratt, D.E., Feng, F.Y.

Volltext

How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: Can reduction of inflammation improve ESA dose response? von Kovesdy, Csaba P

Volltext

C108 GETTING INFLAMED: MARKERS OF LUNG INJURY AND REMODELLING: Investigating Genome Wide Dna Methylation In Bronchial And Lung Fibroblasts From Healthy Individuals And Individuals... von Clifford, R L, Fishbane, N, Rajasekar, P, MacIsaac, J L, McEwen, L M, Fisher, A, Kobor, M, Knox, A J, Hackett, T-L

Volltext

S133 Investigating genome wide dna methylation in airway and parenchymal fibroblasts from healthy individuals and individuals with copd von Clifford, RL, Fishbane, N, Rajasekar, P, Fisher, AJ, Kobor, MS, Knox, AJ, Hackett, TL

Volltext

B58 BIG AND BIGGER (DATA): OMICS AND BIOMARKERS OF COPD AND OTHER CHRONIC LUNG DISEASES: Genome-Wide Association Study Identifies Novel Loci Associated With Fev1 Decline Over 11 Ye... von Fishbane, N, Obeidat, M, Hansel, N N, Rafaels, N, Mathias, R A, Ruczinski, I, Beaty, T H, Barnes, K, Pare, P D, Sin, D D

Volltext

B58 BIG AND BIGGER (DATA): OMICS AND BIOMARKERS OF COPD AND OTHER CHRONIC LUNG DISEASES: Age, Sex And Genetic Factors Are Associated With Response To Ipratropium Among Individuals... von Obeidat, M, Fishbane, N, Hansel, N N, Rafaels, N, Mathias, R A, Ruczinski, I, Beaty, T H, Barnes, K, Pare, P D, Sin, D D

Volltext

How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The use of iron supplementation to reduce ESA dosing in hemodialysis von Shirazian, Shayan, Grant, Candace, Miller, Ilene, Fishbane, Steven

Volltext

How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The itsy bitsy anemia problem von Singh, Ajay K

Volltext

A73 BEYOND CIGARETTE SMOKE IN COPD: Club Cell Secretory Protein 16 (cc16) Is Causally Related To Lung Function Decline In Individuals With Chronic Obstructive Pulmonary Disease Usi... von Obeidat, M, Zhou, G, Li, X, Burgess, S, Fishbane, N, Hansel, N N, Bosse, Y, Joubert, P, Hao, K, Nickle, D, Postma, D S, Timens, W, Rafaels, N, Mathias, R, Ruczinski, I, Beaty, T, Barnes, K, Pare, P D, Sin, D D

Volltext

How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients? von Battistella, Marisa, Chan, Christopher T

Volltext

How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients? von Shah, Hitesh H., Fishbane, Steven N.

Volltext

How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients? von Shirazian, Shayan, Grant, Candace, Miller, Ilene, Fishbane, Steven

Volltext

How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients? von Kovesdy, Csaba P

Volltext